Published in Cancer Weekly, April 26th, 2005
"The effects of activating endogenous protein kinase C (PKC) on cell proliferation and the cell cycle were investigated by treating the breast cancer cell line SKBR-3 with phorbol 12-myristate 13 acetate (PMA). This inhibited cell growth in a concentration-dependent manner, causing a marked arrest of cells in G(1).
"Pretreatment with GF109203X completely blocked the antiproliferative effect of PMA, and pretreatment with the PKCdelta inhibitor rottlerin partially blocked it," scientists in Japan report.
"Infecting SKBR-3 cells with an adenovirus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.